# OnCo record lymphoma-tx-hepatitis-b-reactivation (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-tx-hepatitis-b-reactivation/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-tx-hepatitis-b-reactivation" ;
  schema:name "Hepatitis B reactivation before rituximab and other anti-CD20 antibodies"@en ;
  schema:alternateName "HBV reactivation"@en, "Entecavir prophylaxis"@en, "Anti-HBc positive"@en ;
  schema:description "Anyone who has ever had hepatitis B can have the virus wake up when rituximab strips out their B cells, sometimes months later and sometimes fatally. A blood test before the first dose, and a tablet for those who need it, prevents almost all of it."@en ;
  schema:url <https://onco.cc/terms/lymphoma-tx-hepatitis-b-reactivation/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2014.15704> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/obinutuzumab/>, <https://onco.cc/drugs/glofitamab/>, <https://onco.cc/drugs/epcoritamab/>, <https://onco.cc/drugs/mosunetuzumab/> ;
  onco:terms <https://onco.cc/terms/lymphoma-tx-pjp-and-infection-prophylaxis/> .